EUSA Pharma

Developer of late-stage oncology, pain control and critical care products based in the United Kingdom. The company offers biopharmaceutical products focused on oncology and rare diseases, for the treatment of oral mucositis, a common and debilitating side-effect of radiotherapy and high dose chemotherapy.